Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$1.98 +0.17 (+9.39%)
At close: Nov 12, 2026 · 4:00 PM EST

Harvard Apparatus Regenerative Technology (HRGN) Current Deferred Revenue (2025 - 2026)

Updated

Harvard Apparatus Regenerative Technology (HRGN) recorded Current Deferred Revenue of $603,000 in Q2 2026, up 304.7% from $149,000 a year earlier and up 77.4% from the prior quarter.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Harvard Apparatus Regenerative Technology reported Current Deferred Revenue of $252,000.

  • Per Business Quant, the preceding three quarters came in at $340,000 (Q1 2026), $252,000 (Q4 2025) and $128,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Harvard Apparatus Regenerative Technology 2.32 Mn -1.70 Mn 12,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 690,000.00
Jun 30, 2026 603,000.00
Mar 31, 2026 340,000.00
Dec 31, 2025 252,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 149,000.00
Mar 31, 2025 299,000.00
API Access

Harvard Apparatus Regenerative Technology Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HRGN&period=max&api_key=YOUR_API_KEY